| 英文別名： |
3BETA-HYDROXYCOMPACTIN, NA;(BETA R,DELTA R,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-BETA,DELTA,6-TRIHYDROXY-2-METHYL-8-[(2S)-2-METHYL-1-OXOBUTOXY]-1-NAPHTHALENEHEPTANOIC ACID MONOSODIUM SALT;(BETAR, DELTAR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-BETA, DELTA,6-TRIHYDROXY-2-METHYL-8[(2S)-2-METHYL-1-OXOBUTOXYL]-1-NAPHTHALENEHEPTANOIC ACID SODIUM;(BETA-R,DELTA-R,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-BETA,DELTA,6-TRIHYDROXY-2-METHYL-8[(2S)-2-METHYL-1-OXOBUTOXYL]-1-NAPHTHALENEHEPTANOIC ACID NA;ELISOR;EPTASTATIN SODIUM;KOPOSTAT;MEVALOTIN;PRAVACHOL;PRAVASELECT;PRAVASTATIN SODIUM;PRAVASTATIN SODIUM SALT;2-alpha,6-alpha,8-beta(r*),8a-alpha))-*;cs-514;epastatinsodium;lipostat;sq31000 utoxy)-beta,delta,6-trihydroxy-,monosodiumsalt,(1s-(1-alpha(beta-s*,delta-s;Pravastatin Sodium (US Pat 1981);Pravastatin (sodium salt);Pravastatin (sodium);PRAVASTATIN SODIUM EP5;PRAVASTATIN SODIUM(RG);(βR,δR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-β,,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt;[1S-[1a(bS,dS),2a,6b,8b(R),8aa]]-1,2,6,7,8,8a-Hexahydro-b,d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic acid monosodium salt |
| 中文別名： |
普伐他汀鈉;1,2,6,7,8,8a-六氫-2-甲基-8-(2-甲基丁酰氧基)-1-萘-3',5',6-三羥基庚酸鈉鹽;Pravastatin Sodium 普伐他汀鈉;結(jié)合雌激素;普伐他丁鈉;普伐他汀;普伐他汀鈉 USP標準品;普伐他汀鈉 標準品;普伐他汀鈉鹽;普伐他汀鈉鹽標準品;普伐他汀鈉,{1S-[1α（βS*,δS*）,2α,6α,8β（R*）,8aα]}-1,2,6,7,8,8a-六氫- 2- 甲基-8-（2-甲基-1-氧丁氧基）-β,δ,6-三羥基-1-萘庚酸鈉鹽 |
滬公網(wǎng)安備 31011502020044號
危險化學(xué)品經(jīng)營許可證
水濤